4//SEC Filing
Boston Megan 4
Accession 0000899243-23-018119
CIK 0001808898other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 5:13 PM ET
Size
8.0 KB
Accession
0000899243-23-018119
Insider Transaction Report
Form 4
Boston Megan
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock
2023-08-11+25,907→ 25,907 total - Purchase
Common Warrants (right to buy)
2023-08-11+25,907→ 25,907 totalExercise: $3.86From: 2023-08-11Exp: 2028-08-11→ Common Stock (25,907 underlying)
Holdings
- 20(indirect: By Boston Super Invest Pty A/C Boston Family Super)
Common Stock
Footnotes (2)
- [F1]Represents shares of common stock, par value $0.0001 per share (the "Common Stock") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93.
- [F2]The reported number of shares has been adjusted to reflect the impact of the Issuer's 17-for-1 reverse stock split completed on July 26, 2023.
Documents
Issuer
Benitec Biopharma Inc.
CIK 0001808898
Entity typeother
Related Parties
1- filerCIK 0001808923
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 5:13 PM ET
- Size
- 8.0 KB